Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment

BACKGROUND AND OBJECTIVE Although nanoparticle preparations have great potential in the treatment of tumors, nanoparticle preparations have not achieved the desired therapeutic effect. The reason is that the abnormal tumor microenvironment prevents nanoparticles from effective concentrating and reaching tumor area. Therefore, it's very necessary to better understand the effect of the abnormal tumor microenvironment on the transvascular transport of nanoparticles to overcome this critical problem. METHODS In this paper, a tumor abnormal vascular-interstitial model was established, and the transvascular transport process of nanoparticles was simulated in the model by computational fluid dynamics (CFD) modeling. RESULTS The simulation results showed that the transport efficiency of nanoparticles decreased with increasing interstitial fluid pressure (IFP), and nanoparticles could not cross the blood vessel wall when the IFP approached the blood vessel wall pressure. Interestingly, the transport efficiency of nanoparticles first increased with blood flow velocity, and then decreased with blood flow velocity. CONCLUSIONS The results showed that with the continuous malignant development of tumors, the ability of nanoparticles to passively diffuse has almost disappeared. The enhanced permeability and retention (EPR) effect of the nanoparticles disappeared with the disappearance of the pressure gradient inside the tumor. These results provided guidance for future research on the vascular transport pathways and mechanisms of nanoparticles.

[2]  Triantafyllos Stylianopoulos,et al.  Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. , 2018, Trends in cancer.

[3]  Jedd D. Wolchok,et al.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy , 2016, Nature Reviews Clinical Oncology.

[4]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[5]  R. Jain,et al.  Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.

[6]  M Ancukiewicz,et al.  Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.

[7]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[8]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[9]  C. Pozrikidis,et al.  Numerical simulation of blood and interstitial flow through a solid tumor , 2010, Journal of mathematical biology.

[10]  Timothy W. Secomb,et al.  Transport of drugs from blood vessels to tumour tissue , 2017, Nature Reviews Cancer.

[11]  Jinming Gao,et al.  Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.

[12]  R. Kerbel Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer? , 2006, Science.

[13]  Jian Du,et al.  Advances in mathematical models of the active targeting of tumor cells by functional nanoparticles , 2020, Comput. Methods Programs Biomed..

[14]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[15]  R. Jain Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Ahmed Zeeshan,et al.  Heat transfer analysis on peristaltically induced motion of particle-fluid suspension with variable viscosity: Clot blood model , 2016, Comput. Methods Programs Biomed..

[17]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[18]  K. O'Byrne,et al.  A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer , 2002, British Journal of Cancer.

[19]  Junda Zheng,et al.  Numerical simulation of particle transport and deposition in the pulmonary vasculature. , 2014, Journal of biomechanical engineering.

[20]  Ahmed Zeeshan,et al.  Endoscope analysis on peristaltic blood flow of Sisko fluid with Titanium magneto-nanoparticles , 2016, Comput. Biol. Medicine.

[21]  Chor Yong Tay,et al.  Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.

[22]  Jifu Tan,et al.  Computational Modeling of Nanoparticle Targeted Drug Delivery , 2012 .

[23]  Rakesh K. Jain,et al.  Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.

[24]  Xin-guo Jiang,et al.  Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels. , 2017, Cancer letters.

[25]  Dai Fukumura,et al.  Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model , 2012, Annals of Biomedical Engineering.

[26]  S. Wilhelm,et al.  The entry of nanoparticles into solid tumours , 2020, Nature Materials.

[27]  M. M. Bhatti,et al.  Study of variable magnetic field and endoscope on peristaltic blood flow of particle-fluid suspension through an annulus , 2016 .

[28]  M. M. Bhatti,et al.  Numerical Modelling for Nanoparticle Thermal Migration with Effects of Shape of Particles and Magnetic Field Inside a Porous Enclosure , 2020 .

[29]  M. M. Bhatti,et al.  Study of Activation Energy on the Movement of Gyrotactic Microorganism in a Magnetized Nanofluids Past a Porous Plate , 2020, Processes.

[30]  Huajian Gao,et al.  A non-equilibrium thermodynamic model for tumor extracellular matrix with enzymatic degradation , 2017 .

[31]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[32]  Min Wu,et al.  The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. , 2013, Journal of theoretical biology.

[33]  R. Jain,et al.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.